ImmunoCellular is a L.A.-based clinical stage company developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular’s pipeline includes: a Stem-to-T-cell research program, which engineers hematopoietic stem cells to generate […]
Sierra Oncology’s Cancer Therapies Target the DNA Damage Response Network
Sierra Oncology is a clinical stage drug development company advancing targeted DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer. The company’s lead drug candidate, SRA737, is a highly […]
TapImmune Enrolls 50% in Phase 2 Triple Negative Breast Cancer Study
TapImmune Inc, a clinical-stage immuno-oncology company specializing in the development of immunotherapies targeting women’s cancers, announced that it has enrolled 50% (40/80) of the patients in its randomized Phase 2 clinical study […]
ProLung’s Improved Outcomes for Lung Cancer Patients via Early Predictive Technologies
ProLung’s mission is to improve outcomes for potential lung cancer patients through early predictive technologies, provide cost savings to patients, payers, and providers, and to provide a fair return on investment to […]
Fusion Genomics Advances Molecular Diagnostics
Fusion Genomics is a company that is working to advance molecular diagnostics through developing tests for pathogens that cause disease. They do this using proprietary technologies in combination with Next Generation Sequencing. […]
The Sentinel Breakthroughs in Health & Technology | Trends in Finance | April 8th, 2017
IN THIS ISSUE: FEATURE: New Drugs in Opiate Addiction Battle. As the overdose statistics continue to rise the need for innovative ways to deal with the Opiate epidemic. Can new drugs be […]
Leap Therapeutics’ Antibodies to Treat Cancer
Leap Therapeutics, Inc. (LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, recently reported financial results for the year ended December 31, 2016 and top-line progression-free survival (PFS) data. Earlier this year, Leap […]
Genprex’s 21st Century Gene Therapies for Cancer
Genprex is a clinical-stage biopharmaceutical company developing targeted molecular therapies for cancer. The company is developing molecular therapies that control universal cancer pathways to unlock the unrealized potential of targeted cancer therapies, such […]
